echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > CRISPR gene editing in the brain to treat Alzheimer's disease shows potential

    CRISPR gene editing in the brain to treat Alzheimer's disease shows potential

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease (AD) is the most common neurodegenerative disease among the elderly.
    Among them, familial Alzheimer's disease (FAD) is a genetic disease caused by genetic mutations
    .


    These patients have mutations in genes related to amyloid processing, leading to AD symptoms at a younger age


    Recently, an international research team led by scientists from the Hong Kong University of Science and Technology has developed an innovative technology that enables extensive gene editing in the brain
    .


    In the AD mouse model, the pathogenesis of AD was significantly reduced


    In this study, scientists designed a gene editing therapy based on CRISPR-Cas9
    .


    This gene editing therapy, after being injected into the brain, can specifically disrupt the amyloid precursor (APP) gene carrying genetic mutations in a wide range of brain tissues, thereby significantly reducing the level of amyloid protein in the animal's brain


    ▲The deposition of amyloid in the brain area of ​​mice treated with gene editing therapy (right) was significantly reduced (picture source: reference [1])

    Moreover, the researchers also designed an AAV vector that can cross the blood-brain barrier, which can effectively deliver the gene editing system to the brain with only one intravenous injection
    .


    Experimental results show that this therapy can also alleviate the deposition of amyloid, and alleviate the proliferation of microglia, neurodegeneration, and cognitive impairment


    Reference materials:

    [1] HKUST Scientists Develop Genome-editing Strategy for Potential Alzheimer's Disease Therapy.


    [2] Duan et al.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.